KerstenS, DesvergneB, WahliW. Roles of PPARs in health and disease. Nature2000;405:421–424
2.
BarrosoI, GurnellM, CrowleyVE, AgostiniM, SchwabeJW, SoosMA, MaslenGL, WilliamsTD, LewisH, SchaferAJ, ChatterjeeVK, O'RahillyS. Dominant negative mutations in human PPAR-gamma associated with severe insulin resistance, diabetes mellitus, and hypertension [see comments]. Nature1999;402:880–883.
3.
LawRE, GoetzeS, XiXP, JacksonS, KawanoY, DemerL, FishbeinMC, MeehanWP, HsuehWA. Expression and function of PPAR-gamma in rat and human vascular smooth muscle cells. Circulation2000;101:1311–1318.
4.
StaryHC, BlankenhornDH, ChandlerAB, GlagovS, InsullWJr, RichardsonM, RosenfeldME, SchafferSA, SchwartzCJ, WagnerWD, . A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation1992;85:391–405.
5.
JiangC, TingAT, SeedB. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature1998;391:82–86.
6.
RicoteM, LiAC, WillsonTM, KellyCJ, GlassCK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature1998;391:79–82.
CushingSD, BerlinerJA, ValenteAJ, TerritoMC, NavabM, ParhamiF, GerrityR, SchwartzCJ, FogelmanAM. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A1990;87:5134–5138.
13.
RajavashisthTB, AndalibiA, TerritoMC, BerlinerJA, NavabM, FogelmanAM, LusisAJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modifying low density lipoproteins. Nature1990;344:254–257.
14.
PlumpAS, SmithJD, HayekT, Aalto-SetalaK, WalshA, VerstuyftJG, RubinEM, BreslowJL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell1992;71:343–353.
15.
SmithJD, TroganE, GinsbergM, GrigauxC, TianJ, MiyataM. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factors (op) and apolipoprotein E. Proc Natl Acad Sci U S A1995;92:8264–8268.
16.
GuL, OkadaY, ClintonSK, GerardC, SukhovaGK, LibbyP, RollinsBJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell1998;2:275–281.
